Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hamza Lasla
Observed names:
H Lasla,
H. Lasla,
Lasla, Hamza
Institution:
Institut de Cancérologie de l'Ouest
Observed institutions:
Centre National de la Recherche Scientifique,
Inserm,
Institut de Cancérologie de l'Ouest,
Université de Nantes,
Nantes Université
ORCID:
0000-0003-2348-6907
Observed ORCID:
0000-0003-2348-6907
OpenAlex ID:
A5077349622
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
2015
·
Pascal Jézéquel
, Delphine Loussouarn
, et al.
·
Breast Cancer Research
·
357
PDF
bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses
2021
·
Pascal Jézéquel
, Wilfried Gouraud
, et al.
·
Database
·
220
PDF
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
2019
·
Pascal Jézéquel
, Olivier Kerdraon
, et al.
·
Breast Cancer Research
·
124
PDF
STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment
2020
·
Steven Lohard
, Nathalie Bourgeois
, et al.
·
Nature Communications
·
123
PDF
Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [18F]FDG PET/CT in Early Triple-Negative Breast Cancer
2022
·
Clément Bouron
, Clara Mathie
, et al.
·
Cancers
·
36
PDF
p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors
2016
·
A Chiche
, M Moumen
, et al.
·
Oncogene
·
26
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype
2024
·
Pascal Jézéquel
, Hamza Lasla
, et al.
·
Breast Cancer
·
24
Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches
2020
·
Fadoua Ben Azzouz
, Bertrand Michel
, et al.
·
Computers in Biology and Medicine
·
20
PDF
iTRAQ‐Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple‐Negative Breast Cancer Tumors
2019
·
Pascal Jézéquel
, Catherine Guette
, et al.
·
PROTEOMICS
·
16
Gene-expression signature functional annotation of breast cancer tumours in function of age
2015
·
Pascal Jézéquel
, Zein Sharif
, et al.
·
BMC Medical Genomics
·
10
PDF
Proteomics of tumor and serum samples from isocitrate dehydrogenase‐wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?
2024
·
Anne Clavreul
, Catherine Guette
, et al.
·
Molecular Oncology
·
7
Wnt signaling promotes inflammation and EMT-associated gene expression in mesenchymal TNBC
2026
·
Ramón García-Areas
, Elodie Girard
, et al.
·
Scientific Reports
·
4
PDF
Intérêt de l’outil web bc-GenExMiner en oncologie
2021
·
Pascal Jézéquel
, Wilfried Gouraud
, et al.
·
Bulletin du Cancer
·
4
PDF
A DIA ‐ MS ‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients
2025
·
Anne Clavreul
, François Guillonneau
, et al.
·
Molecular Oncology
·
3
PDF
Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
2022
·
Agnes Basseville
, Chiara Cordier
, et al.
·
Cancer Research Communications
·
2
PDF
Évaluation des performances du logiciel SubtlePET® dans le post-traitement d’images acquises avec réduction de temps par tomographie par émission de positons
2025
·
A. Dambrain
, H. Lasla
, et al.
·
Médecine Nucléaire
270P Dissecting molecular heterogeneity of luminal breast cancers using an ion mobility DIA proteomic approach
2024
·
A. Patsouris
, H. Lasla
, et al.
·
Annals of Oncology
Prediction of pathological response to neo-adjuvant chemotherapy using texture parameters of initial 18-FDG PET/CT in estrogen receptor positive/Her2 negative (ER+/HER2-) early breast cancer (eBC).
2024
·
Hugo Corda
, Hamza Lasla
, et al.
·
Journal of Clinical Oncology
Abstract PO2-15-05: Mesenchymal-like immune-activated: the 4th robust triple-negative breast cancer molecular subtype
2024
·
Mario Campone
, Pascal Jézéquel
, et al.
·
Cancer Research
Author response for "Proteomics of tumor and serum samples from isocitrate dehydrogenase‐wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?"
2024
·
Anne Clavreul
, Catherine Guette
, et al.
·
Publons reviews and discussion
Author response for "Proteomics of tumor and serum samples from isocitrate dehydrogenase‐wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?"
2024
·
Anne Clavreul
, Catherine Guette
, et al.
·
Publons reviews and discussion
Data from Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
2023
·
Agnes Basseville
, Chiara Cordier
, et al.
Supplementary Data from Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
2023
·
Agnes Basseville
, Chiara Cordier
, et al.
Data from Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy
2023
·
Agnes Basseville
, Chiara Cordier
, et al.
Abstract P5-02-37: Multi-omics approach to identify markers of resistance to endocrine therapy + CDK4/6 inhibitors in first line HR+/HER2- metastatic breast cancer (MBC) patients
2023
·
Jean Sebastien FRENEL
, Fadoua Ben Azzouz
, et al.
·
Cancer Research
Show more works
View as search
Works count:
79
Citation count:
1,019
H-index:
10
I10-index:
10
Year
Topic
Type